New pill aims to clear stubborn skin plaques
NCT ID NCT07251998
Summary
This study is testing whether an investigational oral drug called ICP-332 can safely and effectively reduce the skin plaques and symptoms of moderate-to-severe psoriasis. About 172 adults with a significant history of psoriasis will be randomly assigned to receive either the real drug or a placebo pill for comparison. The main goal is to see if the drug can improve skin clearance by at least 75% after 12 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Dermatology Hospital
RECRUITINGShanghai, Shanghai Municipality, 200443, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.